Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enerside Energy S.A. | 9O8 | Nov 25, 2024 | 3.90 | 0.00 |
Enersize | 9H0 | Nov 25, 2024 | 0.00 | 0.00 |
EnerSys | FDN | Nov 25, 2024 | 93.20 | -0.05 |
Enertime | E0T | Nov 25, 2024 | 0.15 | 0.00 |
Engcon AB | 917 | Nov 25, 2024 | 10.00 | +3.63 |
Enghouse Systems Ltd | 3E4 | Nov 25, 2024 | 19.90 | 0.00 |
Engie | GZFB | Nov 25, 2024 | 15.20 | -0.65 |
Engie Brasil Energia S A American Depositary Receipts - Spon | 7TE1 | Nov 25, 2024 | 5.75 | 0.00 |
Engie EPS | 8XE | Nov 25, 2024 | 1.20 | 0.00 |
Engie SA | GZF | Nov 25, 2024 | 15.11 | -2.30 |
Engineer Gold Mines Ltd | 9EG0 | Nov 25, 2024 | 0.02 | +4.55 |
Enhabit | X34 | Nov 25, 2024 | 7.15 | +2.14 |
Eni ADR | ENI1 | Nov 25, 2024 | 28.20 | +3.68 |
Eni SpA | ENI | Nov 25, 2024 | 13.72 | -1.21 |
Eniro | EN8A | Nov 25, 2024 | 0.03 | -0.71 |
ENKA INSAAT (U.ADR)/4 TN1 | ENP | Nov 25, 2024 | 4.82 | 0.00 |
Enlivex Therapeutics Ltd. - Ordinary Shares | 1BT | Nov 25, 2024 | 0.88 | +10.76 |
ENN ENERGY | XGH | Nov 25, 2024 | 6.15 | +0.82 |
ENN ENERGY HLD.UNS.ADR/25 | XGH0 | Nov 25, 2024 | 24.40 | +0.83 |
ENNOGIE SOL.GRP. NAM. DK1 | B0W | Nov 25, 2024 | 0.86 | -1.82 |
Enochian Biosciences Inc | 2Q5 | Nov 25, 2024 | 0.46 | +4.69 |
Enogia S.A | 7BZ | Nov 25, 2024 | 1.50 | +0.33 |
Enova International, Inc. | 27E | Nov 25, 2024 | 99.00 | +4.76 |
ENOVIS CORP. | C520 | Nov 25, 2024 | 44.60 | +1.36 |
Enphase Energy, Inc. | E0P | Nov 25, 2024 | 67.23 | +7.12 |
EnPro Industries Inc | EP9 | Nov 25, 2024 | 179.00 | +1.70 |
EnQuest PLC | 3EQ | Nov 25, 2024 | 0.14 | +2.64 |
ENRG ELEMENTS LTD. | O9B | Nov 25, 2024 | 0.00 | 0.00 |
Enstar Group Limited - Ordinary Shares | 48R | Nov 25, 2024 | 300.00 | 0.00 |
Entain plc | 6GI | Nov 25, 2024 | 8.84 | -2.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.